产品说明
拉坦前列素(游离酸)的类似物,前列腺素(PG)类似物
该产品包含在以下化合物库中:
质量控制
化学性质
CAS号 | 1088434-86-9 | | |
别名 |
分子式 | C32H38O5S3 | 分子量 | 598.8 |
溶解性 | Soluble in DMSO | 储存条件 | Store at -20° |
实验操作
细胞实验[2]: |
细胞系 | |
溶解方法 | |
反应时间 | |
应用 | |
动物实验[3]: |
动物模型 | |
剂量 | |
注意事项 | |
References: |
产品描述
ACS 67 is an analog of latanoprost acid.
Latanoprost, an F-series prostaglandin (PG) analog, has been approved for use as an ocular hypotensive drug for the treatment of glaucoma clinically. Latanoprost is an isopropyl ester, a prodrug form which is converted to free latanoprost acid by endogenous esterase enzymes.
In vitro: In previous study, ACS 67 was found to be able to increase the reduced glutathione levels in normotensive pigmented rabbits significantly after single administration in a dose-dependent manner. Furthermore, in glaucomatous pigmented rabbits after repeated 5-day administration, ACS 67 could also increase the GSH levels when compared with latanoprost. In addition, it was found that ACS 67 could significantly increase the cGMP levels in glaucomatous pigmented rabbits and these data with the combination supported that the increase of cGMP was due to the sulfurated moiety of ACS 67. Moreover, the tolerability was measured in New Zealand albino rabbits at three different concentrations of ACS 67, and results indicated that ACS 67 was very well tolerated in Draize test [1].
In vivo: So far, there in no animal in vivo data reported.
Clinical trial: Up to now, ACS 67 is still in the preclinical development stage.
Reference:
[1] E. Perrino, C. Uliva, C. Lanzi, et al. New prostaglandin derivative for glaucoma treatment. Bioorganic & Medicinal Chemistry Letters 19, 1639-1642 (2009).
温馨提示:不可用于临床治疗。